Cargando…
Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
Despite recent advances in surgical and multimodal therapies, the overall survival (OS) of advanced colorectal cancer (CRC) patients remains low. Thus, discerning sensitive prognostic biomarkers to give the optimistic treatment for CRC patients is extremely critical. N6-methyladenosine (m6A) and lon...
Autores principales: | Li, Zhiyong, Liu, Yang, Yi, Huijie, Cai, Ting, Wei, Yunwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561883/ https://www.ncbi.nlm.nih.gov/pubmed/36246627 http://dx.doi.org/10.3389/fgene.2022.947747 |
Ejemplares similares
-
Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs
por: Wang, Yongfeng, et al.
Publicado: (2023) -
N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
por: Zhang, Peiling, et al.
Publicado: (2021) -
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
por: Zhang, Yuying, et al.
Publicado: (2021) -
Identification of Autophagy-Related LncRNA to Predict the Prognosis of Colorectal Cancer
por: Duan, Ling, et al.
Publicado: (2022) -
Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)